Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hemant Surgical IndustriesBOM:543916 -0.87%80 Pretax Margin % is 9.74% as of Mar. 2026, which is 2% above its 10-year median of 9.51. GuruFocus rates BOM:543916 with a GF Score™ of 80/100 and a GF Value™ of ₹332.62 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Hemant Surgical Industries ranks better than 68.26% on this metric.
The historical rank and industry rank for Hemant Surgical Industries's Pretax Margin % or its related term are showing as below:
BOM:543916'
s Pretax Margin % Range Over the Past 10 Years
Min: 2.54 Med: 9.51 Max: 12.1
Current: 10.18
BOM:543916's Pretax Margin % is ranked better than 68.26% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 2.31
vs BOM:543916: 10.18
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Hemant Surgical Industries Pretax Margin % Related Terms
Hemant Surgical Industries Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543916 vs ABT, SYK, MDT: Pretax Margin % Comparison
For the Medical Devices subindustry, Hemant Surgical Industries's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hemant Surgical Industries Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hemant Surgical Industries's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Hemant Surgical Industries's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hemant Surgical Industries (BOM:543916) has a Pretax Margin % of 9.74% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Hemant Surgical Industries and its competitors. This is near median its historical median of 9.51. Over the past decade, Hemant Surgical Industries' Pretax Margin % has ranged from 2.54 to 12.10. According to the industry distribution chart, Hemant Surgical Industries ranks #259 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 31.7%.
Is Hemant Surgical Industries' Pretax Margin % too high?
Hemant Surgical Industries' current Pretax Margin % of 9.74% is near median its 10-year median of 9.51. Over the past 10 years, this metric has ranged from a low of 2.54 to a high of 12.10. The Medical Devices & Instruments industry median Pretax Margin % is 2.31. Hemant Surgical Industries' value of 9.74% is 321.6% above this industry median. Based on the distribution chart, Hemant Surgical Industries ranks #259 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Hemant Surgical Industries has a GF Score™ of 80/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hemant Surgical Industries' Pretax Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Hemant Surgical Industries ranks #259 out of 816 companies for Pretax Margin %. This puts Hemant Surgical Industries in the upper half of its industry. The industry median Pretax Margin % is 2.31. Hemant Surgical Industries' value of 9.74% is 321.6% above this benchmark. Historically, Hemant Surgical Industries' own Pretax Margin % has ranged from 2.54 to 12.10 over the past decade. While the company's 10-year median is 9.51 vs. the industry median of 2.31, Hemant Surgical Industries has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.31, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hemant Surgical Industries's current Pretax Margin % of 9.74% is 321.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Hemant Surgical Industries and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hemant Surgical Industries's current Pretax Margin % is 9.74%, which is near median its own 10-year median of 9.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hemant Surgical Industries stock overvalued right now?
Based on GuruFocus' analysis, Hemant Surgical Industries (BOM:543916) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹332.62, compared to a current price of ₹380.90 — trading 14.5% above its estimated fair value. The current Pretax Margin % is 9.74%, which is near median its 10-year median of 9.51 and 321.6% above the Medical Devices & Instruments industry median of 2.31. Hemant Surgical Industries' overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Hemant Surgical Industries (BOM:543916), the current Pretax Margin % is 9.74% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hemant Surgical Industries (BOM:543916) Overvalued in 2026?
Based on GuruFocus' analysis, Hemant Surgical Industries stock appears to be overvalued.
The current stock price of ₹380.90 is trading 14.5% above its estimated GF Value™ of ₹332.62.
GuruFocus considers Hemant Surgical Industries to be Modestly Overvalued.
Key valuation signals for BOM:543916:
Pretax Margin %: 9.74% (near median its 10-year median of 9.51)
GF Value™: ₹332.62 vs. price of ₹380.90 (14.5% above fair value)
Industry Position: 321.6% above the Medical Devices & Instruments median (#259 of 816)
No single metric tells the full story. See the BOM:543916 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hemant Surgical Industries Ltd is engaged in Importing, manufacturing, and marketing quality surgical and Pharmaceutical Products at an economical price. Its product offerings cover a wide spectrum of equipment and disposables required for (i) Renal Care, (ii) Cardiovascular Disease, (iii) Respiratory Disease, (iv) Critical Care and Radiology, and (v) Surgical disposables. Its products include JMS Meditape, JMS Infusion Set, JMS Scalp Vein Set, Ventilators, ECG Machines, and others.
80GF Score
Get the complete analysis for BOM:543916
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543916 has been successfully added to your 
